Uniqure announces fda breakthrough therapy designation granted to amt-130 for the treatment of huntington's disease

~ breakthrough therapy designation based on clinical evidence from phase i/ii trials showing meaningful slowing of disease progression ~

AMT Ratings Summary

AMT Quant Ranking